- Home
- CDXS vs JPI Comparison
CDXS vs JPI Comparison
Compare CDXS & JPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- JPI
- Stock Information
- Founded
- CDXS 2002
- JPI 2012
- Country
- CDXS United States
- JPI United States
- Employees
- CDXS N/A
- JPI N/A
- Industry
- CDXS Major Chemicals
- JPI Finance Companies
- Sector
- CDXS Industrials
- JPI Finance
- Exchange
- CDXS Nasdaq
- JPI Nasdaq
- Market Cap
- CDXS 254.3M
- JPI 288.1M
- IPO Year
- CDXS 2010
- JPI N/A
- Fundamental
- Price
- CDXS $2.67
- JPI $20.20
- Analyst Decision
- CDXS Buy
- JPI
- Analyst Count
- CDXS 2
- JPI 0
- Target Price
- CDXS $11.00
- JPI N/A
- AVG Volume (30 Days)
- CDXS 1.3M
- JPI 54.7K
- Earning Date
- CDXS 08-13-2025
- JPI 01-01-0001
- Dividend Yield
- CDXS N/A
- JPI 6.15%
- EPS Growth
- CDXS N/A
- JPI N/A
- EPS
- CDXS N/A
- JPI N/A
- Revenue
- CDXS $57,164,000.00
- JPI N/A
- Revenue This Year
- CDXS $12.88
- JPI N/A
- Revenue Next Year
- CDXS $21.64
- JPI N/A
- P/E Ratio
- CDXS N/A
- JPI N/A
- Revenue Growth
- CDXS N/A
- JPI N/A
- 52 Week Low
- CDXS $1.90
- JPI $16.02
- 52 Week High
- CDXS $6.08
- JPI $19.12
- Technical
- Relative Strength Index (RSI)
- CDXS 42.87
- JPI 42.10
- Support Level
- CDXS $2.74
- JPI $20.00
- Resistance Level
- CDXS $3.06
- JPI $20.42
- Average True Range (ATR)
- CDXS 0.23
- JPI 0.18
- MACD
- CDXS -0.04
- JPI -0.01
- Stochastic Oscillator
- CDXS 4.76
- JPI 31.25
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest
Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.